GlassScriptPhysician profile
Pragya Gupta
NPI 1124331988
$3,516.38
in general payments reported to CMS, 2019-2025
36 companies · $512 in 2025
The $512 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $996 · 2020: $135 · 2021: $591 · 2022: $384 · 2023: $344 · 2024: $554 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,049.01 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $576.91 | 2019-2024 | Breztri, Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.74 | 2019-2025 | Ofev, Jascayd |
| Genzyme Corporation | $166.61 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.36 | 2020-2025 | Glassia |
| Baxter Healthcare | $100.22 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $96.71 | 2021-2025 | Smartvest |
| Mylan Specialty L.P. | $93.98 | 2019-2024 | Yupelri |
| Insmed, INC. | $87.08 | 2022-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $86.29 | 2019-2025 | Dupixent |
| Novo Nordisk INC | $78.21 | 2019 | |
| Grifols USA, LLC | $76.61 | 2024-2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $56.69 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $55.64 | 2022 | |
| Merck Sharp & Dohme LLC | $44.54 | 2019-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $44.36 | 2022-2023 | Tezspire |
| Mallinckrodt Hospital Products INC. | $41.63 | 2021 | |
| Shire North American Group INC | $37.00 | 2019 | |
| Arbor Pharmaceuticals, INC. | $33.54 | 2019 | |
| Amarin Pharma, INC. | $33.38 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.78 | 2019 | |
| Chiesi USA, INC. | $25.10 | 2021 | |
| United Therapeutics Corporation | $23.24 | 2023 | Tyvaso |
| Janssen Pharmaceuticals, INC | $20.12 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $19.09 | 2025 | Lumryz |
| Philips North America LLC | $17.19 | 2019 | |
| Genentech USA, INC. | $16.99 | 2024 | Xolair |
| Abbott Laboratories | $15.69 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $14.98 | 2025 | Opsumit |
| Pfizer INC. | $14.78 | 2019 | |
| Axsome Therapeutics, INC. | $13.35 | 2023 | Sunosi |
| Advanced Respiratory, INC | $13.15 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.90 | 2019 | |
| Tactile Systems Technology INC | $12.45 | 2021 | |
| Harmony Biosciences LLC | $12.39 | 2022 | |
| Inogen, INC. | $10.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pragya Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.